The type I interferon system in idiopathic inflammatory myopathies

Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells

(2009) Sevim Barbasso Helmers et al.   ARTHRITIS AND RHEUMATISM

Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle

(2009) Stina Salomonsson et al.   MUSCLE & NERVE

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies

(2008) M Dastmalchi et al.   ANNALS OF THE RHEUMATIC DISEASES

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies

(2008) O Krystufkova et al.   ANNALS OF THE RHEUMATIC DISEASES

Severe Dermatomyositis Triggered by Interferon Beta-1a Therapy and Associated With Enhanced Type I Interferon Signaling

(2008) Ally-Khan Somani et al.   ARCHIVES OF DERMATOLOGY

Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients

(2007) E Reefman et al.   ANNALS OF THE RHEUMATIC DISEASES